SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-15-009090
Filing Date
2015-11-25
Accepted
2015-11-25 11:55:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 TO FORM SC 13D sc13da1115global_cellularbio.htm SC 13D/A 59643
  Complete submission text file 0001213900-15-009090.txt   61305
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 151255069
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TRINITY CHAMBERS, P.O. BOX 4301 ROAD TOWN TORTOLA D8 00000
Business Address TRINITY CHAMBERS, P.O. BOX 4301 ROAD TOWN TORTOLA D8 00000 (852) 3107-0682
Global Health Investment Holdings Ltd. (Filed by) CIK: 0001569927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: SC 13D/A